| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
U.S. Clinical Chemistry and Immunoassay Reagents Markets Smaller Reagent Manufacturers Find New Solutions to Match LargerManufacturers\' Advantage of Holding Reagent Rental Contracts Clinical laboratories\' enthusiasm for solutions that can help reduce hugeinitial outlays on new instruments is fostering the culture of reagent rentalcontracts. Through such contracts, an instrument manufacturer rents outanalyzers to hospitals or laboratories in exchange for orders for reagents. Thismethod proved to be so popular that it accounted for nearly 75 to 85 percent ofall revenue generated within the clinical chemistry and immunoassay reagentsmarket in 2003. However, it also cut out smaller suppliers from the market.These smaller suppliers have been trying to create niche markets by targetingphysicians\' offices and regional reference laboratories. To cater to the lowerdemand volumes of such sectors, these suppliers have been offering reagents inlower volume packs and using analogs that allow for increased stability ofreagents. This Frost & Sullivan research service examines the U.S. ClinicalChemistry and Immunoassay Reagents Markets and discusses the various markettrends and opportunities for the reagents. The research segments the market intothat for clinical chemistry and immunoassay reagents. It offers revenueforecasts as well as key drivers and restraints affecting market growth. Advances in Point-of-Care and Combinatorial Testing Spur Market Growth The quickness of point-of-care (POC) test results has popularized its useamong the medical community, boosting demand for new, lower volume analyzers toconduct these tests. The need for more instruments is, in turn, driving sales ofadditional reagents. Some of these reagents come in the form of higher marginreagent disks or packs, further enhancing revenue. Continued developments suchas increasing tests menus while decreasing the size of the analyzers' footprintsare likely to further increase uptake of POC testing, and consequently, that ofreagents. The clinical chemistry and immunoassay reagents market is also capitalizingon the advances made in diagnostics. Although new tests provide more informationon medical conditions, many laboratories and hospitals prefer to use acombination of old and new technologies for obtaining a complete picture. Forinstance, in cardiology, specific myoglobin and troponin tests are conducted inaddition to the regular creatine kinase-MB. "These practices augment testvolumes and reagent revenues," says the analyst. Market Growth Expected to Be Mainly Volume Driven In the total market, clinical chemistry dominates in terms of unit volumewith approximately 87.9 percent, while immunoassay reagents lead in revenue withabout 67.8 percent share. This is ample evidence of the \'commodity status\'of most clinical chemistry tests and the growth opportunities for higher marginimmunoassay techniques. In future, the markets for both clinical chemistry andimmunoassay reagents are expected to be driven by volume demand, especially froman ever-increasing aging population. "The educated patient group is becoming more aware of the availabilityof various treatment options and is proactively requesting tests," notesthe analyst. This is bolstering the unit sales of reagents, especially high-endones, since patients have been asking for the latest tests for both earlydiagnosis as well as more comprehensive disease management. Unexpectedepidemiological outbreaks such as SARS are also likely to sporadically increasedemand for reagents and drive volume and revenue. TABLE OF CONTENTS
- EXECUTIVE SUMMARY
- TOTAL MARKET
- Market Overview
- Introduction
- Market Segmentation
- Market Snapshot
- Definitions
- Research Methodology
- Market Dynamics
- Market Challenges
- Strategies
- Market Drivers
- Market Restraints
- Unit and Demand Analysis
- End User Groups
- Unit and Demand Analysis
- Pricing and Revenue Analysis
- Pricing Analysis
- Revenue Forecasts
- Competitive Landscape and Trends
- Competitive Structure
- Market Share Analysis
- Market and Technology Trends
- CLINICAL CHEMISTRY REAGENTS MARKET
- Market Overview
- Introduction
- Select Clinical Chemistry Tests
- Market Engineering Measurements
- Unit and Demand Analysis
- End User Groups
- Unit and Demand Analysis
- Pricing and Revenue Analysis
- Pricing Analysis
- Revenue Forecasts
- Competitive Environment
- Competitive Landscape
- Market Share Analysis
- IMMUNOASSAY REAGENTS MARKETS
- Market Overview
- Introduction
- Select Immunoassay Tests
- Market Engineering Measurements
- Unit and Demand Analysis
- End User Groups
- Unit and Demand Analysis
- Pricing Revenue and Competitive Analysis
- Pricing Analysis
- Revenue Forecasts
- Competitive Environment
- Competitive Landscape
- Market Share Analysis
- FROST & SULLIVAN AWARDS
- Frost & Sullivan Awards
- Award for Technology Innovation
- Award for Product Line Strategy Leadership
- Award for Product Differentiation Leadership
- Award for Product Innovation
- Award for Technology Leadership
- DECISION SUPPORT DATABASES
- Decision Support Databases
- Hospitals
- Physicians
- Biological and Medical Scientists
- Population 55 and Above
- Myocardial Infarction Incidence
- Arthritis Prevalence
- Diabetes Prevalence
- Global Macroeconomic Healthcare Data
|
